PATENT CLAIM ANALYSIS

Application Number: 15995323
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "210210"]

Abstract:
The present invention provides piperidin-4-yl azetidine derivatives, as well as their compositions and methods of use, that modulate the activity of Janus kinase 1 (JAK1) and are useful in the treatment of diseases related to the activity of JAK1 including, for example, inflammatory disorders, autoimmune disorders, cancer, and other diseases.

Claim (Index 81):
The method of  claim 78 , wherein the skin disorder is psoriasis.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 94.0
- Lexical Diversity: 1.42857
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15288641', '13043986', '14289121', '13588776', '13300094']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7805716096434672
- 35 USC 102 Novelty (BERT): 0.5507608021494744
- Combined Prediction Score: 0.757590528894068
- Mean Citation Score: 426.757306
- Max Citation Score: 466.80264000000005
- Similarity Product: 261.2241464764595

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test